Published in J Gen Microbiol on March 01, 1992
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60
Role of toxin functional domains in anthrax pathogenesis. Infect Immun (2000) 1.93
Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect Immun (2004) 1.64
Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers. Nat Struct Mol Biol (2010) 1.62
Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect Immun (1994) 1.61
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50
Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun (2007) 1.45
Membrane translocation by anthrax toxin. Mol Aspects Med (2009) 1.42
Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J Mol Biol (2010) 1.36
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation. PLoS One (2007) 1.16
Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv Drug Deliv Rev (2009) 1.16
Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect Immun (2006) 1.09
Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun (2008) 1.08
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism. PLoS One (2010) 1.03
Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. Proc Natl Acad Sci U S A (2010) 1.03
Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis. Appl Environ Microbiol (1998) 0.99
Death at Sverdlovsk: what have we learned? Am J Pathol (1994) 0.96
Effects of introducing a single charged residue into the phenylalanine clamp of multimeric anthrax protective antigen. J Biol Chem (2010) 0.96
Nano aptasensor for protective antigen toxin of anthrax. Anal Chem (2010) 0.95
An approach to characterizing single-subunit mutations in multimeric prepores and pores of anthrax protective antigen. Protein Sci (2009) 0.93
Bacillus anthracis secretome time course under host-simulated conditions and identification of immunogenic proteins. Proteome Sci (2007) 0.93
Anthrax toxin protective antigen--insights into molecular switching from prepore to pore. Protein Sci (2012) 0.92
Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor. Antimicrob Agents Chemother (2008) 0.91
Cationic polyamines inhibit anthrax lethal factor protease. BMC Pharmacol (2006) 0.88
Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro. Clin Vaccine Immunol (2008) 0.86
Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor. Infect Immun (2002) 0.86
Cellular and physiological effects of anthrax exotoxin and its relevance to disease. Front Cell Infect Microbiol (2012) 0.84
Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. PLoS One (2012) 0.80
Activity of the Bacillus anthracis 20 kDa protective antigen component. BMC Infect Dis (2008) 0.80
Identification of molecular-mimicry-based ligands for cholera diagnostics using magnetic relaxation. Bioconjug Chem (2011) 0.80
Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen. Toxins (Basel) (2011) 0.79
Anthrax toxin-induced rupture of artificial lipid bilayer membranes. J Chem Phys (2013) 0.78
In trans complementation of lethal factor reveal roles in colonization and dissemination in a murine mouse model. PLoS One (2014) 0.78
High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures. Anal Bioanal Chem (2015) 0.77
Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge. Am J Pathol (2014) 0.77
Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives. J Enzyme Inhib Med Chem (2013) 0.75
Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor. Toxins (Basel) (2016) 0.75
Anthrax lethal toxin co-complexes are stabilized by contacts between adjacent lethal factors. J Gen Physiol (2016) 0.75
Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background. PLoS One (2012) 0.75
Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. J Clin Microbiol (1990) 1.48
Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis (1989) 1.43
Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect Immun (1988) 1.30
Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am J Trop Med Hyg (1988) 1.19
Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun (2008) 1.08
Efficacy of a commercial bacterin in protecting strain 13 guineapigs against Bordetella bronchiseptica pneumonia. Lab Anim (1989) 0.77